 Maxim Group reissued their buy rating on shares of BioCardia OTCMKTS:BCDA in a research note issued to investors on Wednesday, AnalystRatings.com reports. Maxim Group currently has a 9.00 target price on the stock. Separately, Zacks Investment Research raised shares of BioCardia from a sell rating to a hold rating in a research note on Monday, ... 